Health Products and Food Branch (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Health Products and Food Branch" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

1thepharmaletter.com

low place

low place

1,712^th place

1,063^rd place

1books.google.com

3^rd place

3^rd place

low place

low place

low place

low place

low place

low place

books.google.com

Sunit K. Singh, Jens H. Kuhn (2019). Defense Against Biological Attacks: Volume I. Springer. ISBN 9783030030537.

canada.ca

Minister of Health, Health Products and Food Branch (16 May 2014). "Guidance Document Submission and Information Requirements for Extraordinary Use New Drugs (EUNDs)" (PDF). Minister of Public Works and Government Services Canada.

doi.org

Henry, B.; Gadient, S. (2017). "Canada's pandemic vaccine strategy". Canada Communicable Disease Report. 43 (7/8): 164–167. doi:10.14745/ccdr.v43i78a05. PMC 5764724. PMID 29770084.
Blouin, D. (2004). "Canada signs agreements to potentially share drug information with the US and Australia". Canadian Medical Association Journal. 171 (2): 121. doi:10.1503/cmaj.1041031. PMC 450348. PMID 15262871.

dww.com

"Canadian Approval Pathway Created For Extraordinary-Use New Drugs". Deeth Williams Wall LLP. 2011-05-04.

edqm.eu

"Memoranda of Understanding and Agreements". EDQM Council of Europe. Retrieved 3 April 2021.

gazette.gc.ca

"Regulations Amending the Food and Drug Regulations (1319 — New Drugs for Extraordinary Use)". P.C. 2011-452. Vol. 145, no. 8 — April 13, 2011. Canada Gazette, Part II. March 25, 2011.

nih.gov

ncbi.nlm.nih.gov

Henry, B.; Gadient, S. (2017). "Canada's pandemic vaccine strategy". Canada Communicable Disease Report. 43 (7/8): 164–167. doi:10.14745/ccdr.v43i78a05. PMC 5764724. PMID 29770084.
Blouin, D. (2004). "Canada signs agreements to potentially share drug information with the US and Australia". Canadian Medical Association Journal. 171 (2): 121. doi:10.1503/cmaj.1041031. PMC 450348. PMID 15262871.

pubmed.ncbi.nlm.nih.gov

Henry, B.; Gadient, S. (2017). "Canada's pandemic vaccine strategy". Canada Communicable Disease Report. 43 (7/8): 164–167. doi:10.14745/ccdr.v43i78a05. PMC 5764724. PMID 29770084.
Blouin, D. (2004). "Canada signs agreements to potentially share drug information with the US and Australia". Canadian Medical Association Journal. 171 (2): 121. doi:10.1503/cmaj.1041031. PMC 450348. PMID 15262871.

thepharmaletter.com

"Canada amends market authorization for 'extraordinary use new drugs'". The Pharma Letter. 13 July 2011.